U. S. SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 


 

FORM 10-Q

 

(Mark One)

 

ý

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2005

 

 

 

o

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

 

 

 

For the transition period from        to       

 

Commission File Number: 001-15667

 

PRECIS, INC.

(Name of business issuer in its Charter)

 

OKLAHOMA

 

73-1494382

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

2040 North Highway 360
Grand Prairie, Texas 75050

(Address of principal executive offices)

 

(866) 578-1665

(Issuer’s telephone number)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ý  No  o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

 

 

 

Yes o  No ý

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

 

 

Yes o  No ý

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS

 

Indicate by check mark whether the registrant filed all documents and reports required to be filed by Section 12, 13 or
15(d) of the Exchange Act after the distribution of securities under a plan confirmed by a court.         Yes  
ý  No  o

 

APPLICABLE ONLY TO CORPORATE ISSUERS

 

State the number of shares outstanding of each of issuer’s classes of common equity, as of the latest practicable date:  As of November 14, 2005, 13,184,269 shares of the issuer’s common stock, $0.01 par value, were outstanding.

 



 

PRECIS, INC.

 

FORM 10-Q
For the Quarter Ended September 30, 2005

 

TABLE OF CONTENTS

 

Part I.

Financial Information

3

 

 

 

Item 1.

Financial Statements (Unaudited)

3

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

3

 

 

 

Item 3.

Quantitative and Qualitative Disclosure of Market Risk

13

 

 

 

Item 4.

Controls and Procedures

13

 

 

 

Part II.

Other Information

15

 

 

 

Item 1.

Legal Proceedings

15

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

17

 

 

 

Item 3.

Defaults Upon Senior Securities

17

 

 

 

Item 4.

Submission of Matters to a Vote of Security Holders

17

 

 

 

Item 5.

Other Information

17

 

 

 

Item 6.

Exhibits

18

 

 

 

SIGNATURES

 

19

 

Throughout this report the first personal plural pronoun in the nominative case form “we” and its objective case form “us”, its possessive and the intensive case forms “our” and “ourselves” and its reflexive form “ourselves,”  refer collectively to Precis, Inc., its subsidiaries, and their executive officers and directors.

 

2



 

Part I.     Financial Information

 

Item 1.           Financial Statements (Unaudited)

 

Our financial statements which are prepared in accordance with Regulation S-X are set forth in this report beginning on page 20.

 

Item 2.           Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion is qualified in its entirety by the more detailed information in our Form 10-K and the financial statements contained in this report, including the notes thereto, and our other periodic reports filed with the Securities and Exchange Commission since December 31, 2004 (collectively referred to as the “Disclosure Documents”). Certain forward-looking statements contained in this report and in the Disclosure Documents regarding our business and prospects are based upon numerous assumptions about future conditions that may ultimately prove to be inaccurate and actual events and results may materially differ from anticipated results described in the forward-looking statements.  Our ability to achieve these results is subject to the risks and uncertainties discussed in our Form 10-K.  Any forward-looking statements contained in this report represent our judgment as of the date of this report.  We disclaim, however, any intent or obligation to update these forward-looking statements. As a result, the reader is cautioned not to place undue reliance on these forward-looking statements.

 

Consumer Healthcare Savings

 

We offer savings on healthcare services throughout the United States to persons who are uninsured, under-insured, or have elected to purchase only high deductible or limited benefit medical insurance policies. These savings are achieved by accessing the same preferred provider organizations (PPOs) that are utilized by many insurance companies.   We sell these programs primarily through a network marketing strategy under the retail name Care Entrée™. Our programs are also marketed by our wholesale clients under our “For Your Good Health” label or the privately labeled brandname of our client.  Our private label clients usually sell memberships in these programs through a combination of marketing methods supported by a customer service call center that allows prospective members to call for more information (in-bound direct marketing). We design these programs to benefit healthcare providers as well as the members. Providers commonly give reduced or preferred rates to PPO networks in exchange for steerage of patients. However, the providers must still file claim forms and wait 30 to 60 days to be paid for their services. Our programs utilize these same networks to obtain the same savings for the Care Entrée™ program members. However, the healthcare providers are paid much more promptly without the involvement of the typical claims review processes of an insurance company. We provide transaction facilitation services to both the program member and the healthcare provider.

 

 Included in this segment and commencing in the third quarter of 2005, we began offering neutraceuticals, consisting of vitamins, minerals and other nutritional supplements, under the Natrience brand.  These are marketed together with wellness services such as access to telephonic physician services and discounted lab testing.  These are sold through a network marketing strategy.  Sales commenced in late September 2005 and were not material to the results of operations for that quarter.

 

Employer and Group Healthcare Services

 

 We also offer full-third party administration services through our wholly-owned subsidiary, Access HealthSource, Inc. (“Access”).  On June 18, 2004, we acquired Access for a purchase price of $3,666,000, consisting of a $2,000,000 payment and delivery of 448,486 shares of our common stock having an agreed value of $1,400,000 at closing and payment of $266,000 in acquisition cost including investment banking, valuation and legal and accounting fees.  Additional payment and stock delivery obligations under that purchase agreement are based on operating performance of Access subsequent to its acquisition.  With respect to the three month periods ended March 31, June 30, and September 30, 2005, we incurred the obligations to pay $560,000, $525,000, and $625,000 respectively, and deliver 320,473 common stock shares (valued at $560,000) and 575,134 common stock shares (valued at $525,000) and 452,896 common shares (valued at $625,000), respectively.  These payments and deliveries were made within the 30 days following the end of those quarters to which they relate.  Through Access, we now provide a wide range of healthcare claims administration services and other cost containment procedures that are frequently required by state and local governmental entities and other large employers that have chosen to self fund their required healthcare benefits. Access helps us offer a more complete suite of healthcare service products.  Also through Access, we provide individuals and employee groups access to preferred provider networks, medical escrow accounts and full third-party administration capabilities to adjudicate and pay medical claims.

 

Access’ services are sold through health insurance and employee benefit brokers and agents.  From a sales distribution standpoint, we also may have the opportunity to grow Access’ regional business through our independent marketing representatives, some of whom sell both to individuals and employer groups throughout the United States.  Access’ primary area of expertise is in the public-sector market. Moreover, we have realized certain intangible benefits from the acquisition.  For instance, we have broadened the management responsibilities of several members of Access’ management team to company-wide roles.  Our new President and Chief Operating Officer, Frank Apodaca, is the President and Chief Executive Officer of Access, and he has implemented, on a

 

3



 

company-wide basis, operational procedures that have proven successful at Access.  Additionally, Access’ David Wysong was recently named Vice-President of Business Development on a company-wide basis.

 

Membership Programs

 

Through Foresight, Inc., we also design non-healthcare related membership programs for rental-purchase companies, financial organizations, employer groups, retailers and association-based organizations. Memberships in these programs are also offered and sold as part of a point-of-sale transaction or by direct marketing through direct mail or as an insert. Program members are offered and provided with our and third-party vendors’ products and services. The products and services are bundled, priced and marketed to target the profiled needs of the clients’ particular customer base. Among the products and services offered are (i) consumer product extended warranties, (ii) tire and wheel guarantee, (iii) insurance products included as association benefits, (iv) emergency travel and living expense reimbursement, (v) access to air ambulance evacuation services, (vi) identity theft protection, (vii) savings on veterinary care, (viii) retail and entertainment discounts, (ix) grocery coupons,  (x) a retail savings coupon book, (xi) emergency roadside assistance, and (xii) auto deductible expense reimbursement. Substantially all of our non-healthcare related membership service programs are offered and sold at retail by clients engaged in the rental-purchase industry.

 

Financial Services

 

Through our subsidiary, Care Financial of Texas, L.L.C. (“Care Financial”), we offer high deductible and scheduled benefit insurance policies, life insurance and annuities.  The high deductible and scheduled benefit insurance policies offer affordable, well-rounded solutions for individuals and employers who are no longer able to afford or obtain traditional health insurance policies.  Commission revenue related to these policies amounted to $263,000 for the nine months ended September 30, 2005.  The insurance policies are sold through our independent marketing representatives who are licensed insurance agents and other licensed agents who are not Care Entree independent marketing representatives.  Additionally, we offer health savings accounts (HSAs), Healthcare Reimbursement Arrangements (HRAs) and medical and dependent care Flexible Spending Accounts (FSAs) offered through Care125, a division of our Foresight, Inc. subsidiary (“Foresight”).  Our Care125 services allow employers to offer additional benefits to their employees and give employees additional tools to manage their healthcare and dependent care expenses.  Our Care125 programs and our medical savings programs can be sold together by agents and brokers with whom we have contracted to offer a more complete benefit package to employers.

 

Critical Accounting Policies

 

Revenue Recognition

 

Healthcare Membership Revenues

 

We recognize our Care Entrée™ program membership revenues, other than initial enrollment fees, on each monthly anniversary date. Membership revenues are reduced by the amount of estimated refunds.  For members that are billed directly, the billed amount is collected almost entirely by automated clearinghouse, electronic check or by electronic charge to the members’ credit cards. The settlement of those charges occurs within a day or two. Under certain private label arrangements, our private label partners bill their members for the membership fees and our portion of the membership fees is periodically remitted to us. During the time from the billing of these private-label membership fees and the remittance to us, we record a receivable from the private label partners and record an estimated allowance for uncollectible amounts.  The allowance of uncollectible receivables is based upon review of the aging of outstanding balances, the credit worthiness of the private label partner and its history of paying the agreed amounts owed.

 

Membership enrollment fees, net of direct costs, are deferred and amortized over the estimated membership period that averages eight to ten months. Independent marketing representative fees, net of direct costs, are deferred and amortized over the term of the applicable contract. Judgment is involved in the allocation of costs to determine the direct costs netted against those deferred revenues, as well as in estimating the membership period over which to amortize such net revenue. We maintain a statistical analysis of the costs and membership periods as a basis for adjusting these estimates from time to time.

 

Access Third Party Administration

 

Access’ principal sources of service revenues include administrative fees for third party claims administration, network provider fees for the preferred provider network and utilization and management fees.  These fees are based on monthly or per member per month fee schedules under specified contractual agreements.  Revenues from these services are recognized in the periods in which the services are performed and when collection is reasonably assured.

 

Commission Expense

 

Commissions are paid to our independent marketing representatives in the month following the month in which a member has enrolled in our Care Entrée™ program. Commissions are only paid in the following month when we have received the related

 

4



 

monthly membership fees. We do not pay advanced commissions on membership sales.  Commissions are based on established commission schedules and are determined and accrued based upon the recognition of the related healthcare membership revenue, as described above.

 

Acquisitions

 

As discussed above, in 2004, we acquired Access for $3,666,000 that includes $2,304,000 of goodwill, $1,400,000 of contracts acquired, $274,000 of working capital and $206,000 of fixed assets, offset by $518,000 of deferred tax liability.   Furthermore, we agreed to make additional purchase price payments and stock deliveries if Access were to achieve and exceed certain operating performance levels.  Additional consideration of $1,120,000 was paid in April based on Access’ first quarter 2005 performance, $1,051,000 was paid in July based on Access’ second quarter 2005 performance, and $1,250,000 was accrued at September 30, 2005, based upon Access’ third quarter 2005 performance.  The increased purchase price was recorded as a $3,421,000 addition to goodwill, increasing goodwill attributable to the Access acquisition to $5,725,000 at September 30, 2005 from $2,304,000 at December 31, 2004.  The allocation of $5,725,000 to goodwill (including amounts recorded at the initial closing) was considered appropriate, as Access strategically complements the Company’s healthcare service offering.

 

Fixed Assets

 

Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives of the related assets for financial reporting purposes. Leasehold improvements are depreciated using the straight-line method over the shorter of their estimated useful lives or the lease term.

 

The estimation of useful lives is based, in part, upon past experience with similar assets and upon our plans for the utilization of the assets in the future.  We periodically review fixed assets, including software, whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable or their depreciation or amortization periods should be accelerated. When any value impairment is determined to exist, the related assets are written down to their fair value. If we determine that the remaining useful life, based upon known events and circumstances, should be shortened, the depreciation or amortization of the related asset is adjusted on a prospective, going-forward basis based upon the shortened useful lives.

 

Intangible Asset Valuation

 

Our intangible assets as of September 30, 2005, consist primarily of goodwill of $14,902,000.  Goodwill represents the excess of acquisition costs over the fair value of net assets acquired. Goodwill is not amortized. Additionally, intangible assets include $1,295,000 of contracts, net of amortization, acquired as part of our acquisition of Access. During the year ended December 31, 2004, our intangible assets were reduced by $2,000,000 to reflect impairment of the goodwill related to our acquisition of Foresight, Inc. in 2000.  During the three months ended June 30, 2005, our intangible assets were further reduced by $9,900,000 to reflect impairment of goodwill related to our acquisition of The Capella Group, Inc. and its Care Entrée™ program in 2001.

 

Income Taxes

 

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the basis of assets and liabilities for financial and income tax reporting. The net deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled.  During the three months ended September 30, 2005, we evaluated the probability of recognizing the benefit of deferred tax assets through the reduction of taxes otherwise payable in the future and increased the allowance by $31,000 to $281,000 against the carrying amount of the deferred tax assets because in our opinion it is more probable than not that some of those assets will not be realized.

 

Reclassifications

 

                Certain prior period amounts have been reclassified to conform to the current period’s presentation.

 

5



 

Results of Operations

 

Consumer Healthcare Savings

 

The operating results for our Consumer Healthcare Savings segment were as follows:

 

 

 

 

For the Three Months Ended

 

For the Nine Months Ended

 

 

 

September 30,

 

September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

Revenues

 

$

4,931

 

$

7,902

 

$

16,746

 

$

26,138

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Cost of operations

 

2,026

 

3,164

 

6,508

 

9,581

 

Sales and marketing

 

1,480

 

2,566

 

5,254

 

8,482

 

General and administrative

 

1,247

 

1,676

 

4,987

 

4,930

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

4,753

 

7,406

 

16,749

 

22,993

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

$

178

 

$

496

 

$

(3

)

$

3,145

 

 

Certain prior period amounts have been reclassified to conform to the current period’s presentation.

 

Service Revenues.  Our Consumer Healthcare Savings programs having been under continuing pressure from increasing competition and regulatory scrutiny, as well as the unwillingness of some healthcare providers to accept our savings cards based on concerns over assurance of payment. In late 2002, we implemented an escrow account requirement to address provider concerns over assurance of payment.  While this feature has shown success in improving acceptance by providers, it has made our programs more complex and difficult to sell. As of September 30, 2005, the percentage of our individual members who have escrowed funds with us was approximately 43.6% of the total individual healthcare membership base. This excludes our private label programs, where the escrow requirements have not been mandated.   In some of the states in which we have a significant number of members, especially Florida, Texas and California, our healthcare savings products are under scrutiny and criticism by state regulators and officials. This regulatory scrutiny has impaired our ability to market these products in those states and elsewhere, further contributing to the decline in membership enrollments and increases in terminated memberships. The table below reflects the decline in our Consumer Healthcare Savings program membership over the preceding 18 months:

 

Care Entrée Membership

(Count at End of Quarter)

 

 

 

March 31,

 

June 30,

 

September 30,

 

December 31,

 

March 31,

 

June 30,

 

September 30,

 

 

 

2004

 

2004

 

2004

 

2004

 

2005

 

2005

 

2005

 

Member Count

 

79,087

 

74,617

 

63,840

 

56,955

 

51,895

 

46,514

 

41,958

 

Percent Change

 

-2.70

%

-5.65

%

-14.44

%

-10.78

%

-8.88

%

-10.37

%

-9.79

%

 

As a result, revenues from our Consumer Healthcare Savings program during the 2005 third quarter declined by $2,971,000 or 37.6% to $4,931,000, from $7,902,000 in the 2004 third quarter. During the nine months ended September 30, 2005, revenues from our Consumer Healthcare Savings program were $16,746,000, a decrease of $9,392,000 or 35.9%, from $26,138,000 during the comparable 2004 period.  The reduction in revenues was primarily due to continuing membership declines, as described above.

 

Although the implementation of escrow requirements negatively impacted our membership base and consequently our revenues and net earnings in 2004 and the first nine months of 2005, the escrow requirements were necessary to provide some assurance of payment to the healthcare providers and, accordingly, their continued willingness to provide healthcare services to our members. This strategic move was critical to our long-term operational and financial viability in the health card savings market, as many healthcare providers throughout the United States will no longer accept a “health discount” card. We are currently exploring additional alternatives that may address the healthcare providers’ concerns related to assurance of payment and that may be better received by potential members as well as our current members. The likelihood of success of new healthcare product offerings is difficult to predict. Therefore, the long-term impact, whether favorable or unfavorable, of the introduction of a new or restructured healthcare savings product on revenues and net earnings may remain unknown for a substantial period following their introduction.

 

The growth of our members’ escrow or cash-in-trust to $5,481,000 as of September 30, 2005 from $4,922,000 as of December 31, 2004 and from $4,837,000 as of September 30, 2004, provides some indication that, while overall memberships have continued to decline, those members who do participate in the escrow-based form of our healthcare savings program continue to increase their escrow deposits with us.

 

6



 

In the third quarter of 2005, we have continued the measures and initiatives commenced earlier in the year to improve our operating efficiencies and performance, especially through cost reductions.  These measures and initiatives include (i) the integration of Access management members with our management team, as mentioned, (ii) the termination of certain equipment capital leases, (iii) personnel reductions and other cost reduction actions, (iv) the exploration of additional products to compliment our core healthcare savings product, and (v) the providing additional compensatory incentives to our independent marketing representatives. These measures have successfully reduced the cost structure associated with our Care Entrée™ and private label membership programs.  We believe the annualized estimated cost savings will be significant.

 

Cost of Operations.  Cost of operations for the three months ended September 30, 2005 decreased $1,138,000 or 36.0%, to $2,026,000 from $3,164,000 during the 2004 comparable period.   Cost of operations was 41.1% of revenues during the three months ended September 30, 2005 and 40.0% during the comparable 2004 period.  The decrease in cost of operations was primarily due to decreases in fixed costs described above, as well as decreased variable costs of $741,000 related to decreased revenue in our Consumer Healthcare Savings segment.  Cost of operations for the nine months ended September 30, 2005 decreased $3,073,000 or 32.1%, to $6,508,000 from $9,581,000 during the 2004 comparable period.   Cost of operations was approximately 38.9% of revenues during the nine months ended September 30, 2005, while during the comparable 2004 period cost of operations was 36.7% of revenues.  The decrease in cost of operations was primarily due to decreases in fixed costs described above, as well as decreased variable costs of$2,263,000 related to decreased revenue in our Consumer Healthcare Savings segment.

 

Sales and Marketing Expenses.  Sales and marketing expenses decreased $1,086,000 or 42.3%, to $1,480,000 during the three months ended September 30, 2005 from $2,566,000 during the comparable 2004 period.  Sales and marketing expenses represented 30.0% and 32.5% of revenues for the three months ended September 30, 2005 and 2004, respectively.  The decrease in sales and marketing expenses was primarily due to decreases in commissions related to the decreased membership revenue of the Care Entrée™ program.  This commission decrease was accentuated by the departure of independent marketing representatives from the upper ranks of our multi-level marketing network through which our Care Entrée program is offered and elimination of the associated over-ride commissions, resulting in a lower percentage of commissions as a percent of revenue.  Sales and marketing expenses decreased $3,228,000 or 38.0%, to $5,254,000 during the nine months ended September 30, 2005 from $8,482,000 during the comparable 2004 period.  Sales and marketing expenses represented 31.4% and 32.4% of revenues for the nine months ended September 30, 2005 and 2004, respectively.  The decrease in sales and marketing expenses was primarily due to decreases in commissions related to the decreased membership revenue of the Care Entree program. This commission decrease was accentuated by departure of independent marketing representatives from the upper ranks of our multi-level marketing network through which our Care Entrée product is offered and elimination of the associated over-ride commissions, resulting in a lower percentage of commissions as a percent of sales.  This decrease is partially offset by $125,000 of personnel severance costs incurred during the first quarter of 2005.

 

General and Administrative Expenses.  General and administrative expenses decreased $429,000 or 25.6%, to $1,247,000 during the three months ended September 30, 2005 from $1,676,000 during the comparable 2004 period.  General and administrative expenses represented 25.3% and 21.2% of revenues for the three months ended September 30, 2005 and 2004, respectively.  General and administrative expenses for the three months ended September 30, 2005 also included $30,000 of additional legal costs associated with the defense and settlement of litigation and regulatory issues and $31,000 of personnel severance costs.  These increased costs were offset by the cost reduction measures as discussed above, primarily related to reductions in employees and the associated salaries and benefits. General and administrative expenses increased $57,000 or 1.1%, to $4,987,000 during the nine months ended September 30, 2005 from $4,930,000 during the comparable 2004 period.  General and administrative expenses represented 29.8% and 18.9% of revenues for the nine months ended September 30, 2005 and 2004, respectively.   These increased costs were primarily due to $198,000 of additional depreciation expense resulting from an October 1, 2004 adjustment of the estimated useful life of certain in-house developed proprietary software and higher legal costs of $120,000 associated with the defense and settlement of litigation and regulatory issues during the nine months ended September 30, 2005.  These cost increases were partially offset by cost reduction measures as discussed above primarily related to reductions in employees and the associated salaries and benefits.

 

Total Operating Expenses.  During the three months ended September 30, 2005, total operating expenses (consisting of cost of operations, sales and marketing expenses, and general and administrative expenses) decreased $2,653,000 or 35.8%, to $4,753,000 from $7,406,000 during the comparable 2004 period.  Total operating expenses represented approximately 96.4% and 93.7% of revenues for the three months ended September 30, 2005 and 2004, respectively.  The decrease in operating margins was due to the reasons described above (primarily increased legal and personnel severance costs as discussed above).  During the nine months ended September 30, 2005, total operating expenses (consisting of cost of operations, sales and marketing expenses, and general and administrative expenses) decreased $6,244,000 or 27.2%, to $16,749,000 from $22,993,000 during the comparable 2004 period.  Total operating expenses represented approximately 100% and 88.0% of revenues for the nine months ended September 30, 2005 and 2004, respectively.  Total operating expenses for the first nine months of 2005 included officer severance compensation expenses of $281,000 for terminated personnel.

 

Operating Income.  Earnings (before taxes) related to our Consumer Healthcare Savings programs have declined from earnings of $496,000 for the three months ended September 30, 2004 to pre-tax earnings of $178,000 for the three months ended

 

7



 

September 30, 2005.  During the nine months ended September 30, 2005, our operating loss was $3,000, a decrease of $3,148,000 or 100%, from operating income of $3,145,000 during the comparable 2004 period.

 

Employer and Group Healthcare Services

 

The operating results for our Employer and Group Healthcare Services segment were as follows:

 

 

 

For the Three Months Ended

 

For the Nine Months Ended

 

 

 

September 30,

 

September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

Revenues

 

$

2,217

 

$

1,838

 

$

6,436

 

$

2,290

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Cost of operations

 

771

 

652

 

2,190

 

832

 

Sales and marketing

 

 

 

 

 

General and administrative

 

958

 

861

 

2,871

 

970

 

Goodwill impairment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

1,729

 

1,513

 

5,061

 

1,802

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

$

488

 

$

325

 

$

1,375

 

$

488

 

 

Certain prior period amounts have been reclassified to conform to the current period’s presentation.

 

Service Revenues.  The primary element of our Employer and Group Healthcare Services segment is our wholly-owned subsidiary, Access HealthSource, Inc. (“Access”), through which we offer full-third party administration services.  On June 18, 2004, we acquired Access for an initial purchase price of $3,666,000, plus contingent consideration which, to date has totaled $3,421,000 (including accrued consideration of $1,250,000) and may require additional consideration of $2,263,000, if Access continues to exceed its EDITDA goals specified in the acquisition agreement.  Through Access, we now provide a wide range of healthcare claims administration services and other cost containment procedures that are frequently required by state and local governmental entities and other large employers that have chosen to self fund their required healthcare benefits. Access helps us offer a more complete suite of healthcare service products.  Also through Access, we provide individuals and employee groups access to preferred provider networks, medical escrow accounts and full third-party administration capabilities to adjudicate and pay medical claims.

 

Employer and Group Healthcare Services’ revenues during the 2005 third quarter increased by $379,000 or 20.6% to $2,217,000, from $1,838,000 in the 2004 third quarter. This increase results primarily from the addition of a new service contract and expansion of services to two existing customers.  During the nine months ended September 30, 2005, revenues from our Employer and Group Healthcare Services program were $6,436,000, an increase of $4,146,000 or 181% from $2,290,000 during the comparable 2004 period.  Results of operations for Access were only included since the date of its acquisition on June 18, 2004.

 

Cost of Operations.  Cost of operations for the Employer and Group Healthcare Services segment for the three months ended September 30, 2005 increased $119,000 or 18.1%, to $771,000 from $652,000 during the 2004 comparable period.   This increase is primarily a result of the increased revenue discussed above.  Cost of operations was 34.8% of revenues during the three months ended September 30, 2005 and 35.5% during the comparable 2004 period.  Cost of operations for the nine months ended September 30, 2005 increased $1,358,000 or 163%, to $2,190,000 from $832,000 during the 2004 comparable period.   Cost of operations was approximately 34.0% of revenues during the nine months ended September 30, 2005, while during the comparable 2004 period cost of operations was 36.3% of revenues.  Results of operations for Access were only included since the date of its acquisition on June 18, 2004.

 

Sales and Marketing Expenses.  Sales and marketing expenses for the Employer and Group Healthcare Services segment are negligible, as Access maintains direct relationships with its large self-funded clients in the El Paso market and does not utilize advertising or outside sales forces.

 

General and Administrative Expenses.  General and administrative expenses for the Employer and Group Healthcare Services segment increased $97,000 or 11.3%, to $958,000 during the three months ended September 30, 2005 from $861,000 during the comparable 2004 period.  General and administrative expenses represented 43.2% and 46.8% of revenues for the three months ended September 30, 2005 and 2004, respectively.  General and administrative expenses for the Employer and Group Healthcare services segment increased $1,901,000 or 196%, to $2,871,000 during the nine months ended September 30, 2005 from $970,000 during the comparable 2004 period.  General and administrative expenses represented 44.6% and 42.4% of revenues for the three months ended September 30, 2005 and 2004, respectively.  General and administrative expenses as a percentage of revenues declined as certain expenses remained relatively fixed, while revenues increased.

 

8



 

Total Operating Expenses.  During the three months ended September 30, 2005, total operating expenses (consisting of cost of operations and general and administrative expenses) for the Employer and Group Healthcare Services segment increased $216,000 or 14.2%, to $1,729,000 from $1,513,000 during the comparable 2004 period.  Total operating expenses represented approximately 78.0% and 82.3% of revenues for the three months ended September 30, 2005 and 2004, respectively.  The increase in operating margins was due to revenues increasing while certain expenses remained relatively fixed. During the nine months ended September 30, 2005, total operating expenses (consisting of cost of operations general and administrative expenses) increased $3,259,000 or 181%, to $5,061,000 from $1,802,000 during the comparable 2004 period.  Results of operations for Access were only included since the date of its acquisition on June 18, 2004. Total operating expenses represented approximately 78.6% and 78.7% of revenues for the nine months ended September 30, 2005 and 2004, respectively.

 

Operating Income.  Earnings (before taxes) related to our Employer and Group Healthcare Services segment have increased from earnings of $325,000 for the three months ended September 30, 2004 to pre-tax earnings of $488,000 for the three months ended September 30, 2005.  During the nine months ended September 30, 2005, our operating income was $1,375,000, an increase  of $887,000 or 182%, from operating income of $488,000 during the comparable 2004 period.  Results of operations for Access were only included since the date of its acquisition on June 18, 2004.

 

Membership Programs

 

The operating results for our Membership Programs segment were as follows:

 

 

 

For the Three Months

 

For the Nine Months

 

 

 

Ended

 

Ended

 

 

 

September 30,

 

September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

Revenues

 

$

317

 

$

239

 

$

788

 

$

675

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Cost of operations

 

179

 

167

 

473

 

519

 

Sales and marketing

 

70

 

18

 

153

 

91

 

General and administrative

 

16

 

58

 

67

 

183

 

Goodwill impairment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

265

 

243

 

693

 

793

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

$

52

 

(4

)

95

 

(118

)

 

Certain prior period amounts have been reclassified to conform to the current period’s presentation.

 

Service Revenues.  During the three months ended September 30, 2005, revenues for our Membership Programs segment were $317,000, an increase of $78,000, or 32.7%, from $239,000 during the comparable 2004 period.  This segment has not been a core element of our strategic plans for some time, but efforts have been made to maintain or moderately grow the segment’s revenues, while significantly reducing its costs. During the nine months ended September 30, 2005, revenues were $788,000, an increase of $113,000 or 16.8%, from $675,000 during the comparable 2004 period.  This increase in revenue is primarily related to increased volume from existing dealers and a new dealer that was signed in May 2005.

 

Cost of Operations.  Cost of operations for our Membership Programs segment for the three months ended September 30, 2005 increased $12,000 or 7.0%, to $179,000 from $167,000 during the 2004 comparable period.   Cost of operations was 56.3% of revenues during the three months ended September 30, 2005 and 69.8% during the comparable 2004 period.   Cost of operations for the nine months ended September 30, 2005 decreased $46,000 or 8.9%, from $519,000 to $473,000 during the 2005 comparable period.   Cost of operations was approximately 60.0% of revenues during the nine months ended September 30, 2005, while during the comparable 2004 period cost of operations was 76.9% of revenues.  The decrease in cost of operations was primarily due to a decrease in extended warranty claims of $35,000.

 

Sales and Marketing Expenses.  Sales and marketing expenses for our Membership Programs segment increased $52,000 or 296%, to $70,000 during the three months ended September 30, 2005 from $18,000 during the comparable 2004 period.  Sales and marketing expenses represented 22.0% and 7.4% of revenues for the three months ended September 30, 2005 and 2004, respectively.  The increase in sales and marketing expenses was primarily due to an adjustment in 2004 to commissions expense for an over-accrual in previous quarters and increased 2005 commissions related to increased revenue described above.  Sales and marketing expenses increased $62,000 or 68.1%, to $153,000 during the nine months ended September 30, 2005 from $91,000 during the comparable 2004 period.  Sales and marketing expenses represented 19.5% and 13.5% of revenues for the nine months ended September 30, 2005 and 2004, respectively.  The increase in sales and marketing expenses was primarily due to increased revenue described above.

 

General and Administrative Expenses.  General and administrative expenses for our Membership Programs segment

 

9



 

decreased $42,000 or 72.3%, to $16,000 during the three months ended September 30, 2005 from $58,000 during the comparable 2004 period.  General and administrative expenses represented 5.1% and 24.3% of revenues for the three months ended September 30, 2005 and 2004, respectively.  General and administrative expenses for the three months ended September 30, 2005 also included personnel reductions related to management cost reduction initiatives.  General and administrative expenses decreased $116,000 or 63.5%, to $67,000 during the nine months ended September 30, 2005 from $183,000 during the comparable 2004 period.  General and administrative expenses represented 8.5% and 27.1% of revenues for the nine months ended September 30, 2005 and 2004, respectively.   The decrease in general and administrative expenses is primarily due to management cost reduction initiatives.

 

Total Operating Expenses.  During the three months ended September 30, 2005, total operating expenses for our Membership Programs segment (consisting of cost of operations, sales and marketing expenses, and general and administrative expenses) increased $22,000 or 9.0%, to $265,000 from $243,000 during the comparable 2004 period.  Total operating expenses represented approximately 83.4% and 101.6% of revenues for the three months ended September 30, 2005 and 2004, respectively.  The increase in operating expenses is primarily related to commissions related to the new dealer that was signed in May 2005.  During the nine months ended September 30, 2005, total operating expenses (consisting of cost of operations, sales and marketing expenses, general and administrative expenses) decreased $100,000 or 12.6%, to $693,000 from $793,000 during the comparable 2004 period.  Total operating expenses represented approximately 87.9% and 118% of revenues for the nine months ended September 30, 2005 and 2004, respectively.  The increase in operating margins from the first nine months of 2004 to the first nine months of 2005 was due to decreases in extended warranty claims and personnel reductions offset by increased commissions on increased revenues.

 

Operating Income (Loss).  Earnings (before taxes) related to our Membership Programs segment have improved from a pre-tax loss of  $4,000 for the three months ended September 30, 2004 to pre-tax earnings of $52,000 for the three months ended September 30, 2005.  During the nine months ended September 30, 2005, our operating earnings were $95,000, an increase of $213,000 or 181%, from an operating loss of $118,000 during the comparable 2004 period.

 

Financial Services

 

The operating results for our Financial Services segment were as follows:

 

 

 

For the Three Months

 

For the Nine Months

 

 

 

Ended

 

Ended

 

 

 

September 30,

 

September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

Revenues

 

$

71

 

$

312

 

$

303

 

$

538

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Cost of operations

 

23

 

34

 

55

 

92

 

Sales and marketing

 

92

 

254

 

253

 

449

 

General and administrative

 

45

 

291

 

532

 

724

 

Goodwill impairment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

160

 

579

 

840

 

1,265

 

 

 

 

 

 

 

 

 

 

 

Operating loss

 

$

(89

)

$

(267

)

$

(537

)

$

(727

)

 

Certain prior period amounts have been reclassified to conform to the current period’s presentation.

 

Service Revenues.  During the three months ended September 30, 2005, revenues for our Financial Services segment were $71,000, a decrease of $241,000, or 77.3%, from $312,000 during the comparable 2004 period.  This reduction in revenues was primarily due to the continuing decrease in sales of annuities and life insurance policies by our network marketing representatives.  During the nine months ended September 30, 2005, revenues were $303,000, a decrease of $235,000 or 43.7%, from $538,000 during the comparable 2004 period.  The reduction in revenues was primarily due to continuing declines in sales of annuities and life insurance policies by our network marketing representatives.

 

Cost of Operations.  Cost of operations for our Financial Services segment for the three months ended September 30, 2005 decreased $11,000 or 31.8%, to $23,000 from $34,000 during the 2004 comparable period.   Cost of operations was 32.8% of revenues during the three months ended September 30, 2005 and 10.9% during the comparable 2004 period.  Cost of operations for the nine months ended September 30, 2005 decreased $37,000 or 39.8%, to $55,000 from $92,000 during the 2004 comparable period.

 

Sales and Marketing Expenses.  Sales and marketing expenses our Financial Services segment decreased $162,000 or 63.8%, to $92,000 during the three months ended September 30, 2005 from $254,000 during the comparable 2004 period.  Sales and marketing expenses represented 130% and 81.4% of revenues for the three months ended September 30, 2005 and 2004, respectively.  The decrease in sales and marketing expenses was primarily due to decreased commissions related to lower sales as discussed above.

 

10



 

Sales and marketing expenses decreased $196,000 or 43.6%, to $253,000 during the nine months ended September 30, 2005 from $449,000 during the comparable 2004 period.  Sales and marketing expenses represented 83.5% of revenues for the nine months ended September 30, 2005 and 2004.  The decrease in sales and marketing expenses was primarily due to decreased commissions related to lower sales.

 

General and Administrative Expenses.  General and administrative expenses for our Financial Services segment decreased $246,000 or 84.6%, to $45,000 during the three months ended September 30, 2005 from $291,000 during the comparable 2004 period.  General and administrative expenses represented 63.5% and 93.2% of revenues for the three months ended September 30, 2005 and 2004, respectively.  General and administrative expenses for the three months ended September 30, 2005 declined due to the discontinuation of the consulting arrangement related to the management of the insurance sales force.   General and administrative expenses decreased $192,000 or 26.5%, to $532,000 during the nine months ended September 30, 2005 from $724,000 during the comparable 2004 period.  General and administrative expenses represented 176% and 135% of revenues for the nine months ended September 30, 2005 and 2004, respectively.

 

Total Operating Expenses.  During the three months ended September 30, 2005, total operating expenses (consisting of cost of operations, sales and marketing expenses, and general and administrative expenses) for our Financial Services segment decreased $419,000 or 72.3%, to $160,000 from $579,000 during the comparable 2004 period.  Total operating expenses represented approximately 226% and 186% of revenues for the three months ended September 30, 2005 and 2004, respectively.  The decrease in operating expenses was due to the reasons described above (primarily the decline in business and the termination of the consulting arrangement discussed above). During the nine months ended September 30, 2005, total operating expenses (consisting of cost of operations, sales and marketing expenses, and general and administrative expenses) decreased $425,000 or 33.5%, to $840,000 from $1,265,000 during the comparable 2004 period.  Total operating expenses represented approximately 277% and 235% of revenues for the nine months ended September 30, 2005 and 2004, respectively.

 

Operating Loss.  Pre-tax losses related to our Financial Services segment have improved from a loss of  $267,000 for the three months ended September 30, 2004 to a pre-tax loss of $89,000 for the three months ended September 30, 2005.  During the nine months ended September 30, 2005, our pre-tax loss was $537,000, an improvement of $190,000 or 26.0%, from a pre-tax loss of $727,000 during the comparable 2004 period.

 

Corporate

 

General and Administrative Expenses.  General and administrative expenses increased $199,000 or 77.0%, to $458,000 during the three months ended September 30, 2005 from $259,000 during the comparable 2004 period.   General and administrative expenses increased $1,045,000 or 134%, to $1,822,000 (excluding impairment of goodwill of $9,900,000 discussed below) during the nine months ended September 30, 2005 from $777,000 during the comparable 2004 period.   General and administrative expenses for the nine months ended September 30, 2005 included a $775,000 charge resulting from severance compensation payable to some of our former officers. The increased expenses also related to costs associated with auditing fees of $139,000 and investor relations expenses of $39,000.

 

Certain prior period amounts have been reclassified to conform to the current period’s presentation.

 

Impairment of Goodwill.  As discussed above in the Critical Accounting Policies section in the paragraph titled Intangible Asset Valuation, during the three months ended June 30, 2005 we recorded an impairment loss related to The Capella Group, Inc. and its Care Entrée™ program of $9,900,000.  This impairment charge was not allocated to the Consumer Healthcare Savings segment.

 

 

Recent Management Initiatives

 

During the fourth quarter of 2004 and the first quarter of 2005, we undertook certain initiatives to reverse our declining revenues and achieve a decrease in operating expenses. These measures and initiatives include (i) the integration of Access management members with our management team, as mentioned above, (ii) the termination of certain equipment capital leases, (iii) personnel reductions and other cost reduction actions, (iv) the exploration of additional products to compliment our core healthcare savings product, and (v) the providing additional compensatory incentives to our independent marketing representatives.  The results of operations for the three months ended September 30, 2005 reflect some significant results from those efforts, as previously discussed.

 

Income Tax Provision

 

SFAS 109, Accounting for Income Taxes, requires the separate recognition, measured at currently enacted tax rates, of deferred tax assets and deferred tax liabilities for the tax effect of temporary differences between the financial reporting and tax reporting bases of assets and liabilities, and net operating loss carryforwards for tax purposes. A valuation allowance must be established for deferred tax assets if it is “more likely than not” that all or a portion will not be realized. At September 30, 2005 and

 

11



 

December 31, 2004, we had deferred tax benefits of $1,467,000 (after allowance) and $1,801,000, respectively, resulting in large part from net operating loss carryforwards that, if not utilized, will expire at various dates through 2020. The cumulative net deferred tax asset as of September 30, 2005 and December 31, 2004 was $850,000 and $1,146,000, respectively.  A valuation allowance of $250,000 was established as of June 30, 2005 and increased by $31,000 to $281,000 as of September 30, 2005 to reduce the deferred tax asset to an amount that, in our opinion, is more likely than not realizable.  If we continue to incur net operating losses, an additional valuation allowance may need to be established.  Valuation allowance adjustments have a direct impact on net income (loss) in the amount of the allowance.

 

Liquidity and Capital Resources

 

Operating Activities.  Net cash provided by operating activities for the nine months ended September 30, 2005 and September 30, 2004 was $390,000 and $2,787,000, respectively, a decrease of $2,397,000.   The decrease in net cash provided by operating activities for the nine months ended September 30, 2005 was due primarily to the net loss during the period partially offset by receipt of an income tax refund of $733,000 and recovery of IRS penalties of $107,000.

 

Investing Activities.  Net cash used in investing activities for the nine months ended September 30, 2005 and 2004 was $1,294,000 and $2,603,000, respectively, and related primarily to our acquisition of Access (including contingent consideration paid and delivered during 2005, as described previously).

 

Financing Activities.  Net cash used in financing activities for the nine months ended September 30, 2005 was $909,000 as compared to $1,436,000 for the nine months ended September 30, 2004.  During the nine months ended September 30, 2005, net cash used in financing activities was primarily for payments on capital equipment leases of $540,000 and repurchase of 244,054 shares of our common stock for $369,000.

 

At September 30, 2005 and December 31, 2004, we had working capital of $4,283,000 and $6,451,000, respectively.  This decline is due primarily due to contingent consideration paid or accrued on the Access acquisition.  Other than our $558,000 capital lease obligations and our potential payment and delivery obligations associated with the Access acquisition (which are unknown as of the date of this report), we do not have any capital commitments. We do not anticipate that our capital expenditures for the remainder of the year ending December 31, 2005 will exceed the amount incurred during the comparable 2004 period.  We believe that our existing cash and cash equivalents, and cash provided by operations, will be sufficient to fund our normal operations and capital expenditures for the next 12 months.

 

Because our capital requirements cannot be predicted with certainty, including any possible business acquisitions for the remainder of the year ending December 31, 2005, there is no assurance that we will not require any additional financing during the next 12 months, and if required, that any additional financing will be available on terms satisfactory to us or advantageous to our shareholders.

 

Stock Repurchase Plan

 

On July 8, 2004, our Board of Directors authorized the repurchase of up to 500,000 shares of our common stock through open market or private purchase transactions over the next year depending on prevailing market conditions.  Pursuant to this authorization, we purchased 500,000 shares for $1,050,959 at a weighted average price of $2.10 per share. Repurchases of shares were as follows:

 

 

 

 

 

Weighted

 

 

 

 

 

Shares

 

Avg. Stock

 

 

 

Period

 

Purchased

 

Price/Share

 

Total Cost

 

2004

 

255,946

 

$

2.66

 

$

681,434

 

January 2005

 

15,412

 

2.09

 

32,137

 

February 2005

 

29,115

 

2.23

 

65,053

 

March 2005

 

35,450

 

1.91

 

67,722

 

April 2005

 

32,600

 

1.77

 

57,724

 

May 2005

 

131,477

 

1.12

 

146,889

 

 

 

 

 

 

 

 

 

As of September 30, 2005

 

500,000

 

$

2.10

 

$

1,050,959

 

 

Cautionary Statement Relating to Forward Looking Information

 

We have included some forward-looking statements in this section and other places in this report regarding our expectations.  These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements, or industry results, to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Some of these forward-looking statements can be identified by the use of forward-looking terminology including “believes,” “expects,” “may,” “will,” “should” or “anticipates”

 

12



 

or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategies that involve risks and uncertainties.  You should read statements that contain these words carefully because they:

 

                  Discuss our future expectations;

 

                  Contain projections of our future operating results or of our future financial condition; or

 

                  State other “forward-looking” information.

 

We believe it is important to discuss our expectations; however, it must be recognized that events may occur in the future over which we have no control and which we are not accurately able to predict.  Readers are cautioned to consider the specific business risk factors described in our annual report on Form 10-K for the fiscal year ended December 31, 2004 and our Schedule 14A Proxy Statement for our 2005 annual shareholders meeting, and not to place undue reliance on the forward-looking statements contained herein, which speak only as of the date hereof.  We undertake no obligation to publicly revise forward-looking statements to reflect events or circumstances that may arise after the date hereof.

 

Item 3.           Quantitative and Qualitative Disclosures about Market Risk

 

We do not have any investments in market risk sensitive instruments.

 

Item 4.           Controls and Procedures

 

Our Acting Chief Executive Officer and Chief Financial Officer are responsible primarily for establishing and maintaining disclosure controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission. These controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Furthermore, our Acting Chief Executive Officer and Chief Financial Officer are responsible for the design and supervision of our internal controls over financial reporting that are then effected by and through our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial

statements for external purposes in accordance with accounting principles generally accepted in the United States of America. These policies and procedures

 

                                          pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

 

                                          provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and

 

                                          provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

 

In connection with our year-end close process and the preparation of our Annual Report on Form 10-K as of December 31, 2004, an evaluation was performed under the supervision and with the participation of management, including our former Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on that evaluation as of December 31, 2004, our former Chief Executive Officer and Chief Financial Officer concluded that our controls suffered a material weakness, in that losses were probable in the collection of outstanding accounts and notes receivable, but those losses had not been adequately quantified or provided for in the allowance for doubtful accounts.  That material weakness was remediated in the second quarter of 2005.  During the third quarter of 2005, we have continued to implement improvements to internal controls in the areas of (i) information technology (especially disaster recovery and control over the program change process), (ii) information technology application controls over claims transaction processing and (iii) detailed reporting of member statistics.  Our management reported to our auditors and the audit committee of our Board of Directors that, other than the changes just described, no other change in our disclosure controls and procedures and internal control over financial reporting occurred during the third quarter of 2005 that would materially affect or was reasonably likely to materially affect our disclosure controls and procedures or internal control over financial reporting. In conducting their evaluation of our disclosure controls and procedures and internal controls over financial reporting, our management, including our Acting Chief Executive Officer and Chief

 

13



 

Financial Officer, did not discover any fraud that involved management or other employees who have a significant role in our disclosure controls and procedures and internal controls over financial reporting. Furthermore, there were no significant changes in our disclosure controls and procedures, internal controls over financial reporting, or other factors that significantly affect our disclosure controls and procedures or internal controls over financial reporting subsequent to the date of their evaluation, other than the enhanced procedures that are related to accounts receivables as described above.

 

Changes to Internal Control over Financial Reporting

 

There have been no significant changes, other than those discussed above, in the Company’s internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

14



 

PART II OTHER INFORMATION

 

Item 1.                       Legal Proceedings

 

In the normal course of business, we may become involved in litigation or in settlement proceedings relating to claims arising out of our operations. Except as described below, we are not a party to any legal proceedings, the adverse outcome of which, individually or in the aggregate, could have a material adverse effect on our business, financial condition and results of operations.

 

Kirk, et al v. Precis, Inc. and David May

 

On September 8, 2003, the case styled “Robert Kirk, Individually and D/B/A US Asian Advisors, LLC, Eugene M. Kennedy, P.A., Stewart & Associates, CPA’s, P.A. and Kimberly Decamp, Plaintiffs vs. Precis, Inc. and David May, Defendants” was initiated in the District Court of Tarrant County, Texas, Case No. 236 201 468 03. The plaintiffs Robert Kirk (doing business as US Asian Advisors, LLC or U.S. Asian Capital Investors, LLC and recently convicted of securities fraud and related crimes), Kimberly Decamp and Stewart & Associates, CPA’s, P.A. held warrants exercisable for the purchase of 9,000, 48,000 and 4,000 shares, respectively, of our common stock for $9.00 per share on or before February 8, 2005. The plaintiffs Eugene M. Kennedy, P.A. and Kimberly Decamp held stock options that expired on June 30, 2003, and that were exercisable for 15,000 and 170,000 shares, respectively, of our common stock for $9.37 per share. David May was our Secretary and Vice President and General Counsel through January 5, 2004.

 

The plaintiffs alleged that they were not allowed to exercise their stock options and warrants in May of 2003 due to actions and inactions of Mr. May and that these actions and inactions constitute fraud, misrepresentation, negligence and legal malpractice. All communications with Mr. May were through the plaintiffs’ broker, Burt Martin Arnold Securities, Inc. Plaintiffs sought damages equal to the difference between the exercise price of the stock options or warrants and the market value of our common stock on May 7, 2002 (presumably the closing sale price of $15.75) or an aggregate sum of $1,592,050, plus exemplary damages and costs.

 

On July 13, 2005, the court entered a judgment in favor of Precis, ordering that the plaintiffs take nothing by way of their lawsuit.  The order set aside a previous jury verdict in favor of the plaintiffs.  The plaintiffs have appealed the judgment.  While we cannot offer any assurance as to the outcome of the appeal, we do not believe that there exists any basis on which the judgment will be overturned.

 

Zermeno v. Precis

 

The case styled “Manuela Zermeno, individually and on behalf of the general public; and Juan A. Zermeno, individually and on behalf of the general public vs. Precis, Inc., an Oklahoma corporation and Does 1 through 100, inclusive” was filed on August 14, 2003 in the Superior Court of the State of California for the county of Los Angeles.

 

A second case styled “California Foundation for Business Ethics, Inc., a California non-profit corporation, v Precis, Inc., and Does 1 through 100, inclusive” was filed on September 9, 2003, in the Superior Court of the State of California for the county of Los Angeles.

 

The two above cases were removed to the United States District Court for the Central District of California and consolidated, by order of the court, on December 4, 2003.

 

The Zermeno plaintiffs are former members of the Care Entrée™ discount health care program who allege that they (for themselves and for the general public) are entitled to injunctive, declaratory, and equitable relief. Plaintiffs’ First Amended Complaint set forth three distinct claims under California law. Plaintiffs’ first cause of action alleged that the operation of the Care Entrée™ program by Defendants Precis, Inc. and The Capella Group, Inc. violates Health and Safety Code § 445 (“Section 445”), which governs medical referral services. Next, Plaintiffs alleged that they are entitled to damages under Civil Code §§ 1812.119 and 1812.123, which are part of the broader statutory scheme governing the operation of discount buying organizations, Civil Code 1812. 100 et. seq. (“Section 1812.100”). Plaintiffs’ third cause of action sought relief under Business and Professions Code § 17200, California’s Unfair Competition Law.

 

We have fully settled all the claims brought by the California Foundation for Business Ethics, Inc.  With the Zermeno plaintiffs, we have settled the causes of action related to Civil Code §§ 1812.119 and 1812.123.  The claim related to Section 445 and the related claim under Section 17200 remain pending and have been assigned to the Superior Court of California, Los Angeles County under case number BC 300788.  The court ruled on June 28, 2005, that the plaintiffs did not have standing to bring these remaining claims.  The plaintiffs have the opportunity to correct procedural defects and a final hearing is expected in November 2005.  A negative result in this case would have a material affect on our financial condition and would limit our ability (and that of other medical discount cards) to do business in California.

 

15



 

We believe that we have complied with all applicable statues and regulations in the state of California.  Although we believe the Plaintiffs’ claims are without merit, this remaining matter in the case remains pending, and, as of the date of this report, we cannot provide any assurance regarding the outcome or results of this litigation.

 

State of Texas v. The Capella Group, Inc. et al

 

The State of Texas filed a lawsuit against our subsidiary, The Capella Group, Inc. d/b/a Care Entrée and Equal Access Health, Inc. (including various names under which Equal Access Health, Inc. does business), on April 28, 2005.  The lawsuit alleges that Care Entrée directly and through at least one other party that resells Care Entrée’s services to the public, violated certain provisions of the Texas Deceptive Trade Practices — Consumer Protection Act.  The lawsuit seeks, among other things, injunctive relief, monetary penalties and restitution.  The Company believes that the allegations are without merit and will vigorously defend the lawsuit.  The lawsuit was filed in the 98th District Court of Travis County, Texas, under case number GV501264.  We believe that the allegations are without merit and intend on defending the lawsuit.  Care Entrée has always insisted that its programs be sold in an honest and forthright manner and has worked to protect the interests of consumers in Texas and around the country.  Findings against the Company in the lawsuit could result in a material adverse effect on our financial condition and on our operations.  Because the lawsuit remains in its earliest stages, we cannot provide any assurance regarding the outcome or results of this litigation.

 

                                                The Capella Group, Inc., d/b/a/Care Entree v. California Department of Managed Health Care; Lucinda Ehnes, in her official capacity; and Does 1-20 inclusive

 

                On October 18, 2005, our subsidiary, The Capella Group, Inc. d/b/a Care Entrée (“Capella”) initiated in the Superior Court of the State of California, County of Los Angeles Case No. BC341633 styled The Capella Group, Inc., d/b/a/Care Entree v. California Department of Managed Health Care; Lucinda Ehnes, in her official capacity; and Does 1-20 inclusive.  Lucinda Ehnes is the Director of the California Department of Managed Health Care (the “DMHC”).

 

                The DMHC is responsible for the administration and enforcement of the Knox-Keene Health Care Service Act of 1975 (the “Knox-Keene Act”), a set of laws that regulate healthcare maintenance organizations or HMOs and impose licensing requirements on those organizations.  This licensing process is in part to ensure that the financial resources of the HMO are sufficient to cover the cost of providing the promised healthcare.  In 2001 the DMHC issued its interpretive opinion that concluded that the healthcare discount programs like those offered and sold by Capella are not similar to insurance programs that the Knox-Keene Act is intended to regulate and therefore the Act is not applicable.  Accordingly the Company believes that the DMHC does not have jurisdiction over healthcare discount programs like that of Capella’s Care Entrée program.

 

                In the first half of 2005, DMHC initiated an investigation to determine the applicability the Knox-Keene Act to the membership programs offered and sold to California residents as a form of “health care service plan.”  In July 2005, the DMHC issued a Cease and Desist Order, finding that Capella’s Care Entrée discount program is subject to the licensing requirements and regulation under the Knox-Keene Act, effectively under the jurisdiction of the DMHC.

 

                In the lawsuit, Capella is requesting a declaratory judgment finding that the Care Entrée discount program is not a “health care service plan” within the meaning of the Knox-Keene Act and therefore not subject to the Act and that the DMHC has neither the authority nor the jurisdiction to issue the Cease and Desist Order.    In accordance with the Knox-Keene Act, Capella is seeking a declaratory judgment and injunction to prevent enforcement of the Cease and Desist Order by the Director of DMHC.

 

                Because the lawsuit was just filed, the Company cannot determine whether it will be successful in obtaining the declaratory judgment and injunction sought.  Findings against Capella and in favor of the DMHC and its Director could have a material adverse effect on our financial condition and on our operations in California and overall results of operations.

 

16



 

Item 2.                       Unregistered Sales of Equity Securities and Use of Proceeds

 

(a)                         None.

 

(b)                        None.

 

(c)                         Repurchases of the Company’s Treasury Stock during the First and Second Quarters of 2005

 

On July 8, 2004, our Board of Directors authorized the repurchase of up to 500,000 shares of our common stock through open market or private purchase transactions over the next year depending on prevailing market conditions.  As of the filing of this report we have purchased 500,000 shares under this authorization for a total consideration of $1,050,959 at a weighted average price of $2.10 per share. Repurchases of shares were as follows:

 

 

 

 

 

 

 

 

 

Number of

 

 

 

 

 

 

 

Cumulative

 

Shares That

 

 

 

 

 

Weighted

 

Number of

 

May Yet Be

 

 

 

Shares

 

Avg. Stock

 

Shares

 

Purchased

 

Period

 

Purchased

 

Price/Share

 

Purchased

 

under the Plan

 

2004

 

255,946

 

$

2.66

 

255,946

 

244,054

 

January 2005

 

15,412

 

$

2.09

 

271,358

 

228,642

 

February 2005

 

29,115

 

$

2.23

 

300,473

 

199,527

 

March 2005

 

35,450

 

$

1.91

 

335,923

 

164,077

 

April 2005

 

32,600

 

$

1.77

 

368,523

 

131,477

 

May 2005

 

131,477

 

$

1.12

 

500,000

 

 

 

(d)       None.

 

Item 3.                        Defaults upon Senior Securities

 

None.

 

Item 4.                        Submission of Matters to a Vote of Security Holders

 

None.

 

Item 5.                        Other Information

 

None.

 

17



 

Item 6.                       Exhibits

 

 

Exhibit 
No.

 

Description

 

 

 

3.1

 

Registrant’s Certificate of Incorporation, incorporated by reference to Exhibit 3.2 of Registrant’s Form 8-K/A filed with the Commission on June 25, 2001.

 

 

 

3.2

 

Registrant’s Bylaws as amended and restated on April 30, 2003 incorporated by reference to Exhibit 3.2 of Registrant’s Form 10-Q filed with the Commission on May 14, 2003.

 

 

 

4.1

 

Form of certificate of the common stock of Registrant is incorporated by reference to Exhibit 1.1 of Amendment to Registration Statement on Form 8-A, as filed with the Commission on July 31, 2001.

 

 

 

4.2

 

Precis SmartCard, Inc. 1999 Stock Option Plan (amended and restated), incorporated by reference to the Schedule 14A filed with the Commission on May 16, 2001.

 

 

 

4.3

 

Precis, Inc. 2002 IMR Stock Option Plan, incorporated by reference to the Schedule 14A filed with the Commission on June 26, 2002.

 

 

 

4.4

 

Precis, Inc. 2002 Non-Employee Stock Option Plan, incorporated by reference to the Schedule 14A filed with the Commission on June 26, 2002.

 

 

 

31.1

 

Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of Nicholas J. Zaffiris as Chairman of the Board  & Acting Chief Executive Officer.

 

 

 

31.2

 

Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of Robert L. Bintliff as Chief Financial Officer.

 

 

 

32.1

 

Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of Sarbanes-Oxley Act of Nicholas J. Zaffiris as Chairman of the Board and Acting Chief Executive Officer.

 

 

 

32.2

 

Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of Sarbanes-Oxley Act of Robert L. Bintliff as Chief Financial Officer.

 

18



 

SIGNATURES:

 

In accordance with the requirements of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

PRECIS, INC.

 

(Registrant)

 

 

 

Date: November 14, 2005

/s/NICHOLAS J. ZAFFIRIS

 

Chairman of the Board and

 

Acting Chief Executive Officer

 

 

 

 

Date: November 14, 2005

/s/ ROBERT L. BINTLIFF

 

Robert L. Bintliff

 

Chief Financial Officer

 

19



 

INDEX TO FINANCIAL STATEMENTS

 

Condensed Consolidated Balance Sheets as of September 30, 2005 (unaudited) and December 31, 2004 (audited)

 

 

 

Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2005 and 2004

 

 

 

Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the Nine Months Ended September 30, 2005

 

 

 

Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2005 and 2004

 

 

 

Notes to Unaudited Condensed Consolidated Financial Statements

 

 

20



 

PRECIS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands)

 

 

 

September 30,

 

December 31,

 

 

 

2005

 

2004

 

 

 

(unaudited)

 

(audited)

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash in trust

 

$

5,481

 

$

4,922

 

Cash and cash equivalents

 

6,470

 

8,283

 

Accounts receivable, net

 

287

 

312

 

Income tax receivable

 

541

 

980

 

Inventory

 

181

 

174

 

Prepaid expenses

 

714

 

547

 

Current portion of deferred tax asset

 

170

 

106

 

 

 

 

 

 

 

Total current assets

 

13,844

 

15,324

 

 

 

 

 

 

 

Fixed assets, net

 

1,224

 

1,989

 

Goodwill

 

14,902

 

21,381

 

Other intangible assets, net

 

1,295

 

1,400

 

Deferred tax asset, net of current portion

 

680

 

1,040

 

Other assets

 

245

 

186

 

 

 

 

 

 

 

Total assets

 

$

32,190

 

$

41,320

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

367

 

$

470

 

Accrued commissions

 

489

 

731

 

Accrued consideration on business combination

 

1,250

 

 

Other accrued liabilities

 

1,254

 

1,573

 

Franchise taxes payable

 

410

 

509

 

Members’ liabilities

 

5,481

 

4,922

 

Deferred fees

 

42

 

154

 

Current portion of capital leases

 

268

 

514

 

 

 

 

 

 

 

Total current liabilities

 

9,561

 

8,873

 

 

 

 

 

 

 

Capital lease obligations, net of current portion

 

291

 

78

 

 

 

 

 

 

 

Total liabilities

 

9,852

 

8,951

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Common stock, $.01 par value, 100,000,000 shares authorized; 13,231,373 and 12,335,766 issued, and 12,731,373 and 12,079,820 outstanding, respectively

 

132

 

123

 

Additional paid-in capital

 

28,297

 

27,221

 

Accumulated (deficit) earnings

 

(5,040

)

5,707

 

Less: treasury stock (500,000 shares and 255,946 shares, respectively)

 

(1,051

)

(682

)

Total stockholders’ equity

 

22,338

 

32,369

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

32,190

 

$

41,320

 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

21



 

PRECIS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in Thousands, except Earnings per Share)

 

 

 

For the Three Months Ended

 

For the Nine Months Ended

 

 

 

September 30,

 

September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

Revenues

 

$

7,536

 

$

10,291

 

$

24,273

 

$

29,641

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Cost of operations

 

2,998

 

4,018

 

9,226

 

11,024

 

Sales and marketing

 

1,642

 

2,837

 

5,661

 

9,022

 

General and administrative

 

2,725

 

3,145

 

10,278

 

7,584

 

Goodwill impairment

 

 

 

9,900

 

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

7,365

 

10,000

 

35,065

 

27,630

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

171

 

291

 

(10,792

)

2,011

 

 

 

 

 

 

 

 

 

 

 

Other expenses:

 

 

 

 

 

 

 

 

 

Interest (income) and expense, net

 

(60

)

7

 

(99

)

57

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) before taxes

 

231

 

284

 

(10,693

)

1,954

 

Provision for income taxes

 

101

 

188

 

54

 

964

 

 

 

 

 

 

 

 

 

 

 

Net earnings (loss)

 

$

130

 

$

96

 

$

(10,747

)

$

990

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.01

 

$

0.01

 

$

(0.88

)

$

0.08

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

$

0.01

 

$

0.01

 

$

(0.88

)

$

0.08

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

12,556,332

 

12,104,582

 

12,241,476

 

12,103,957

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

12,563,902

 

12,144,133

 

12,241,476

 

12,208,468

 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

22



 

PRECIS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Dollars in Thousands)

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

COMMON STOCK

 

Additional

 

Treasury

 

Earnings

 

 

 

 

 

Shares

 

Amount

 

Paid-in Capital

 

Stock

 

(Deficit)

 

Total

 

Balance, December 31, 2004 (audited)

 

12,335,766

 

$

123

 

$

27,221

 

$

(682

)

$

5,707

 

$

32,369

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchase of 244,054 common shares

 

 

 

 

(369

)

 

(369

)

Net loss

 

 

 

 

 

(10,747

)

(10,747

)

Issuance of stock in business combination

 

895,607

 

9

 

1,076

 

 

 

1,085

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, September 30, 2005 (unaudited)

 

13,231,373

 

$

132

 

$

28,297

 

$

(1,051

)

$

(5,040

)

$

22,338

 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

23



 

PRECIS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Thousands)

 

 

 

For the Nine Months Ended Sept. 30,

 

 

 

2005

 

2004

 

Operating activities:

 

 

 

 

 

Net (loss) earnings

 

$

(10,747

)

$

990

 

Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:

 

 

 

 

 

Depreciation

 

1,391

 

1,660

 

Amortization of intangibles

 

105

 

 

Loss on disposal of fixed assets

 

15

 

¾

 

Provision for losses on accounts receivable

 

345

 

152

 

Goodwill impairment

 

9,900

 

¾

 

Other non-cash items

 

74

 

¾

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(320

)

(215

)

Income taxes receivable

 

439

 

108

 

Inventory

 

(7

)

4

 

Prepaid expenses

 

(167

)

(183

)

Deferred tax asset

 

296

 

250

 

Other assets

 

(59

)

(241

)

Accounts payable

 

(103

)

115

 

Accrued liabilities

 

(561

)

242

 

Deferred fees

 

(112

)

(169

)

Income taxes payable

 

(99

)

74

 

 

 

 

 

 

 

Net cash provided by operating activities

 

390

 

2,787

 

 

 

 

 

 

 

Investing activities:

 

 

 

 

 

Purchase of fixed assets

 

(209

)

(603

)

Cash used in business combination, net of cash acquired

 

(1,085

)

(2,000

)

 

 

 

 

 

 

Net cash used in investing activities

 

(1,294

)

(2,603

)

 

 

 

 

 

 

Financing activities:

 

 

 

 

 

Exercise of stock options

 

¾

 

5

 

Payments on capital leases

 

(540

)

(1,085

)

Purchase of treasury stock

 

(369

)

(356

)

 

 

 

 

 

 

Net cash used in financing activities

 

(909

)

(1,436

)

 

 

 

 

 

 

Net decrease in cash and cash equivalents

 

(1,813

)

(1,252

)

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

8,283

 

11,088

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

$

6,470

 

$

9,836

 

 

 

 

 

 

 

Supplemental disclosure:

 

 

 

 

 

Interest paid

 

$

51

 

$

78

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

Acquisition of fixed assets through issuance of capital leases, net of retirements

 

$

507

 

$

10

 

Accrued cash consideration and stock issuance on business combination

 

$

1,250

 

$

 

Cash-in-trust collected, net of claims paid

 

$

559

 

$

2,069

 

 

See Accompanying Notes to Condensed Consolidated Financial Statements

 

24



 

PRECIS, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 — Interim Financial Information

 

The accompanying condensed consolidated financial statements are unaudited, but include all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position at such dates and of the operations and cash flows for the periods then ended. The financial information is presented in a condensed format, and it does not include all of the footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three and nine months ended September 30, 2005 and 2004 are not necessarily indicative of results that may be expected for the entire year.  The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities and reported amounts of revenues and expenses during the reporting periods under consideration.  Actual results could differ materially from such assumptions and estimates.  The accompanying condensed consolidated financial statements and related footnotes should be read in conjunction with the Company’s audited financial statements, included in its December 31, 2004 Form 10-K filed with the Securities and Exchange Commission.  Certain prior period amounts have been reclassified to conform to the current period’s presentation.

 

 

Note 2 — Common Stock Options

 

As of September 30, 2005, the Company had three stock-based compensation plans.  The Company applies APB 25 and related interpretations in accounting for its plans.  Under APB 25, compensation for services that a corporation receives through stock-based compensation plans should be measured by the excess, if any, of the quoted market price of the stock at the measurement date less the amount, that the individual is required to pay.  No compensation expense was recorded during the three months ended September 30, 2005 and 2004 related to its stock option plans under APB 25.  If the Company had elected to recognize compensation based on the fair value of the options granted at the grant date as prescribed by “Statement of Financial Accounting Standards No. 123 (“SFAS 123”) Accounting for Stock-Based Compensation”, net earnings and net earnings per share would have decreased as shown in the pro forma amounts below for the three and nine months ended September 30, 2005 and 2004.

 

 

 

For the Three Months Ended

 

For the Nine Months Ended

 

 

 

September 30,

 

September 30,

 

(Dollars in Thousands)

 

2005

 

2004

 

2005

 

2004

 

Net earnings applicable to shareholders

 

$

130

 

$

96

 

$

(10,747

)

$

990

 

Deduct: Total stock-based compensation expense determined under fair value based method for all awards, net of related tax effects

 

(39

)

(69

)

(77

)

(295

)

 

 

 

 

 

 

 

 

 

 

Pro forma net earnings (loss)

 

$

91

 

$

27

 

$

(10,824

)

$

695

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Basic — as reported

 

$

0.01

 

$

0.01

 

$

(0.88

)

$

0.08

 

 

 

 

 

 

 

 

 

 

 

Basic — pro forma

 

$

0.01

 

$

0.00

 

$

(0.88

)

$

0.06

 

 

 

 

 

 

 

 

 

 

 

Diluted — as reported

 

$

0.01

 

$

0.01

 

$

(0.88

)

$

0.08

 

 

 

 

 

 

 

 

 

 

 

Diluted — pro forma

 

$

0.01

 

$

0.00

 

$

(0.88

)

$

0.06

 

 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model.  No options were granted during the three-month period ended September 30, 2005.  The following assumptions were used for grants during the three month period ended June 30, 2005: weighted average risk free interest rate of 3.63%; no dividend yield; volatility of 73%; and expected life less than five years.  The fair values of the options were based on the difference between the present value of the exercise price of the option and the estimated fair value price of the common share.

 

The intent of the Black-Scholes option valuation model is to provide estimates of fair values of traded options that have no vesting restrictions and are fully transferable.  Option valuation models require the use of highly subjective assumptions including expected stock price volatility.  The Company has utilized the Black-Scholes method to produce the pro forma disclosures required under SFAS 123.  In management’s opinion, existing valuation models do not necessarily provide a reliable single measure of the fair

value of its employee stock options because the Company’s employee stock options have significantly different characteristics from

 

25



 

those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate.  The effects of applying SFAS 123 in this pro forma are not indicative of future amounts.

 

Note 3 — Earnings Per Share

 

The Company’s earnings per share data was computed as follows:

 

 

 

For the Three Months Ended

 

 

 

September 30,

 

(Dollars in Thousands)

 

2005

 

2004

 

 

 

 

 

 

 

Basic earnings (loss) applicable to common shareholders per share

 

 

 

 

 

Net earnings

 

$

130

 

$

96

 

Weighted average number of common shares outstanding during the period.

 

12,556,332

 

12,104,582

 

Basic earnings per share

 

$

0.01

 

$

0.01

 

 

 

 

 

 

 

Diluted earnings (loss) per share

 

 

 

 

 

Net earnings

 

$

130

 

$

96

 

Weighted average number of common shares outstanding during the period

 

12,556,332

 

12,104,582

 

Stock options

 

7,570

 

39,551

 

Weighted average number of shares outstanding during the period—assumed conversion (1)

 

12,563,902

 

12,144,133

 

Diluted earnings per share

 

$

0.01

 

$

0.01

 

 

 

 

For the Nine Months Ended

 

 

 

September 30,

 

(Dollars in Thousands)

 

2005

 

2004

 

Basic (loss) earnings applicable to common shareholders per share

 

 

 

 

 

Net (loss) earnings

 

$

(10,747

)

$

990

 

Weighted average number of common shares outstanding during the period.

 

12,241,476

 

12,103,957

 

Basic (loss) earnings per share

 

$

(0.88

)

$

0.08

 

 

 

 

 

 

 

Diluted (loss) earnings per share

 

 

 

 

 

Net (loss) earnings

 

$

(10,747

)

$

990

 

Weighted average number of common shares outstanding during the period

 

12,241,476

 

12,103,957

 

Stock options(1)

 

¾

 

104,511

 

Weighted average number of shares outstanding during the period-assumed conversion (1)

 

12,241,476

 

12,208,468

 

Diluted (loss) earnings per share (1)

 

$

(0.88

)

$

0.08

 

 


(1)                                 For the nine months ended September 30, 2005, 13,179 in-the-money shares related to outstanding stock options were not included in the calculation of fully diluted earnings per share because the inclusion would have been anti-dilutive due to a net loss for that period.  The number of stock options and warrants that were considered out-of-the-money for purposes of the diluted earnings per share calculation for the three months ended September 30, 2005 and 2004 was 1,489,764 and 1,336,264, respectively.  The number of stock options and warrants that were considered out-of-the-money for purposes of the diluted earnings per share calculation for the nine months ended September 30, 2005 and 2004 was 1,449,764 and 971,198, respectively.

 

Note 4 — Goodwill

 

Recorded goodwill must be reviewed and analyzed to determine its fair value and possible impairment.  This review and analysis is conducted at least annually, and may be conducted more frequently if an event occurs or circumstances change that would, more likely than not, reduce the fair value of a reporting unit below its carrying amount. The aggregate fair market value of the reporting unit’s assets, including recorded goodwill, in excess of the fair value of the reporting unit’s liabilities, may not exceed the fair value of the reporting unit’s equity. The fair value of the reporting unit’s equity shall be based upon valuation techniques that

estimate the amount at which the reporting unit as a whole could be bought or sold in a current transaction between willing parties.

 

Due to the continuing decline in members and revenues of the Consumer Healthcare Savings segment to a lower level than management had previously predicted and the pending litigation and regulatory activity that was announced in the second quarter of 2005, we completed an impairment test of the goodwill as of June 30, 2005.   Significant judgments and estimates were required in connection with the impairment test to determine the estimated future cash flows and fair value of the reporting unit. An independent valuation consultant was engaged by the Company to estimate fair values for that reporting unit using discounted cash flow projections and other valuation methodologies in evaluating and measuring a potential impairment charge.  Based upon management’s

 

26



 

cash flow projections and the consultant’s independent valuation, the Company recorded an impairment loss related to The Capella Group, Inc. of $9,900,000 in the quarter ended June 30, 2005. To the extent that, in the future, our estimates change or our stock price decreases, further goodwill write-downs may occur.

 

As part of the Access purchase agreement completed June 18, 2004, the Company makes additional purchase price payments and stock deliveries if Access achieves certain operating performance levels.  Additional consideration of $1,120,000 was paid in April based on Access’ first quarter 2005 performance, $1,051,000 was paid in July based on Access’ second quarter 2005 performance, and $1,250,000 was accrued at September 30, 2005, based upon Access’ third quarter 2005 performance.  The increased purchase price was recorded as a $3,421,000 addition to goodwill, increasing goodwill attributable to the Access acquisition to $5,725,000 at September 30, 2005 from $2,304,000 at December 31, 2004.

 

Note 5 — Contingencies

 

Kirk, et al v. Precis, Inc. and David May

 

On September 8, 2003, the case styled “Robert Kirk, Individually and D/B/A US Asian Advisors, LLC, Eugene M. Kennedy, P.A., Stewart & Associates, CPA’s, P.A. and Kimberly Decamp, Plaintiffs vs. Precis, Inc. and David May, Defendants” was initiated in the District Court of Tarrant County, Texas, Case No. 236 201 468 03. The plaintiffs Robert Kirk (doing business as US Asian Advisors, LLC or U.S. Asian Capital Investors, LLC and recently convicted of securities fraud and related crimes), Kimberly Decamp and Stewart & Associates, CPA’s, P.A. held warrants exercisable for the purchase of 9,000, 48,000 and 4,000 shares, respectively, of our common stock for $9.00 per share on or before February 8, 2005. The plaintiffs Eugene M. Kennedy, P.A. and Kimberly Decamp held stock options that expired on June 30, 2003, and that were exercisable for 15,000 and 170,000 shares, respectively, of our common stock for $9.37 per share. David May was our Secretary and Vice President and General Counsel through January 5, 2004.

 

The plaintiffs alleged that they were not allowed to exercise their stock options and warrants in May of 2003 due to actions and inactions of Mr. May and that these actions and inactions constitute fraud, misrepresentation, negligence and legal malpractice. All communications with Mr. May were through the plaintiffs’ broker, Burt Martin Arnold Securities, Inc. Plaintiffs sought damages equal to the difference between the exercise price of the stock options or warrants and the market value of our common stock on May 7, 2002 (presumably the closing sale price of $15.75) or an aggregate sum of $1,592,050, plus exemplary damages and costs.

 

On July 13, 2005, the court entered a judgment in favor of Precis, ordering that the plaintiffs take nothing by way of their lawsuit.  The order set aside a previous jury verdict in favor of the plaintiffs.  The plaintiffs have appealed the judgment.  While we cannot offer any assurance as to the outcome of the appeal, we do not believe that there exists any basis on which the judgment will be overturned.

 

Zermeno v. Precis

 

The case styled “Manuela Zermeno, individually and on behalf of the general public; and Juan A. Zermeno, individually and on behalf of the general public vs. Precis, Inc., an Oklahoma corporation and Does 1 through 100, inclusive” was filed on August 14, 2003 in the Superior Court of the State of California for the county of Los Angeles.

 

A second case styled “California Foundation for Business Ethics, Inc., a California non-profit corporation, v Precis, Inc., and Does 1 through 100, inclusive” was filed on September 9, 2003, in the Superior Court of the State of California for the county of Los Angeles.

 

The two above cases were removed to the United States District Court for the Central District of California and consolidated, by order of the court, on December 4, 2003.

 

The Zermeno plaintiffs are former members of the Care Entrée™ discount health care program who allege that they (for themselves and for the general public) are entitled to injunctive, declaratory, and equitable relief. Plaintiffs’ First Amended Complaint set forth three distinct claims under California law. Plaintiffs’ first cause of action alleged that the operation of the Care Entrée™ program by Defendants Precis, Inc. and The Capella Group, Inc. violates Health and Safety Code § 445 (“Section 445”), which governs medical referral services. Next, Plaintiffs alleged that they are entitled to damages under Civil Code §§ 1812.119 and 1812.123, which are part of the broader statutory scheme governing the operation of discount buying organizations, Civil Code 1812. 100 et. seq. (“Section 1812.100”). Plaintiffs’ third cause of action sought relief under Business and Professions Code § 17200, California’s Unfair Competition Law.

 

We have fully settled all the claims brought by the California Foundation for Business Ethics, Inc.  With the Zermeno plaintiffs, we have settled the causes of action related to Civil Code §§ 1812.119 and 1812.123.  The claim related to Section 445 and the related claim under Section 17200 remain pending and have been assigned to the Superior Court of California, Los Angeles County under case number BC 300788.  The court ruled on June 28, 2005, that the plaintiffs did not have standing to bring these remaining claims.  The plaintiffs have the opportunity to correct procedural defects and a final hearing is expected in November 2005. 

 

27



 

A negative result in this case would have a material affect on our financial condition and would limit our ability (and that of other medical discount cards) to do business in California.

 

We believe that we have complied with all applicable statues and regulations in the state of California.  Although we believe the Plaintiffs’ claims are without merit, this remaining matter in the case remains pending, and, as of the date of this report, we cannot provide any assurance regarding the outcome or results of this litigation.

 

State of Texas v. The Capella Group, Inc. et al

 

The State of Texas filed a lawsuit against our subsidiary, The Capella Group, Inc. d/b/a Care Entrée and Equal Access Health, Inc. (including various names under which Equal Access Health, Inc. does business), on April 28, 2005.  The lawsuit alleges that Care Entrée directly and through at least one other party that resells Care Entrée’s services to the public, violated certain provisions of the Texas Deceptive Trade Practices — Consumer Protection Act.  The lawsuit seeks, among other things, injunctive relief, monetary penalties and restitution.  The Company believes that the allegations are without merit and will vigorously defend the lawsuit.  The lawsuit was filed in the 98th District Court of Travis County, Texas, under case number GV501264.  We believe that the allegations are without merit and intend on defending the lawsuit.  Care Entrée has always insisted that its programs be sold in an honest and forthright manner and has worked to protect the interests of consumers in Texas and around the country.  Findings against the Company in the lawsuit could result in a material adverse effect on our financial condition and on our operations.  Because the lawsuit remains in its earliest stages, we cannot provide any assurance regarding the outcome or results of this litigation.

 

The Capella Group, Inc., d/b/a/Care Entree v. California Department of Managed Health Care; Lucinda Ehnes, in her official capacity; and Does 1-20 inclusive

 

                On October 18, 2005, our subsidiary, The Capella Group, Inc. d/b/a Care Entrée (“Capella”) initiated in the Superior Court of the State of California, County of Los Angeles Case No. BC341633 styled The Capella Group, Inc., d/b/a/Care Entree v. California Department of Managed Health Care; Lucinda Ehnes, in her official capacity; and Does 1-20 inclusive.  Lucinda Ehnes is the Director of the California Department of Managed Health Care (the “DMHC”).

 

                The DMHC is responsible for the administration and enforcement of the Knox-Keene Health Care Service Act of 1975 (the “Knox-Keene Act”), a set of laws that regulate healthcare maintenance organizations or HMOs and impose licensing requirements on those organizations.  This licensing process is in part to ensure that the financial resources of the HMO are sufficient to cover the cost of providing the promised healthcare.  In 2001 the DMHC issued its interpretive opinion that concluded that the healthcare discount programs like those offered and sold by Capella are not similar to insurance programs that the Knox-Keene Act is intended to regulate and therefore the Act is not applicable.  Accordingly the Company believes that the DMHC does not have jurisdiction over healthcare discount programs like that of Capella’s Care Entrée program.

 

                In the first half of 2005, DMHC initiated an investigation to determine the applicability the Knox-Keene Act to the membership programs offered and sold to California residents as a form of “health care service plan.”  In July 2005, the DMHC issued a Cease and Desist Order, finding that Capella’s Care Entrée discount program is subject to the licensing requirements and regulation under the Knox-Keene Act, effectively under the jurisdiction of the DMHC.

 

                In the lawsuit, Capella is requesting a declaratory judgment finding that the Care Entrée discount program is not a “health care service plan” within the meaning of the Knox-Keene Act and therefore not subject to the Act and that the DMHC has neither the authority nor the jurisdiction to issue the Cease and Desist Order.    In accordance with the Knox-Keene Act, Capella is seeking a declaratory judgment and injunction to prevent enforcement of the Cease and Desist Order by the Director of DMHC.

 

                Because the lawsuit was just filed, the Company cannot determine whether it will be successful in obtaining the declaratory judgment and injunction sought.  Findings against Capella and in favor of the DMHC and its Director could have a material adverse effect on our financial condition and on our operations in California and overall results of operations.

 

Other

 

In January 1999, the former parent of Foresight, Inc., Universal Marketing Services, Inc. purchased the outstanding common stock of Foresight, Inc. for $4,540,000. Universal Marketing Services agreed to indemnify the former owners of the common stock of Foresight, Inc. for the increase in federal income taxes and any applicable penalties to the extent that $4,540,000 of the purchase price does not qualify for long-term capital gain treatment. These former shareholders reported $4,540,000 of the purchase price as long-term capital gain. In connection with the Company’s merger- acquisition of Foresight, Inc., the Company assumed the indemnification obligation of Universal Marketing Services. Upon examination, the Internal Revenue Service may take the position that a portion of the $4,540,000 should be classified as ordinary income taxable at the maximum federal income tax rate of 39.6% rather than the long-term capital gain 20% rate. In the event the Internal Revenue Service successfully asserts that long-term capital gain classification was improper, the Company will be required to indemnify the former shareholders.

 

28



 

The Company has an unused letter of credit in the amount of $1,500,000 obtained on commercial terms. The letter of credit is due to expire on June 6, 2006.

 

On June 18, 2004, the Company completed its acquisition of Access HealthSource, Inc. (“Access”), a third party administrator, from National Center for the Employment of the Disabled for a purchase price of $3,666,000, consisting of 488,486 shares of common stock of the Company valued at $1,400,000 ($2.87 per share), and $2,000,000 in cash and acquisition cost of investment banking, valuation and legal and accounting fees of $266,000.  In addition to the purchase price consideration, there is a contingency payout should the earnings before interest, taxes, depreciation and amortization (“EBITDA”) of Access reach certain amounts after the closing of the transaction and before December 31, 2006.  EBITDA, while not considered a measure under accounting principles generally accepted in the United States of America, is the financial measurement utilized for the basis of the contingency payout and additional purchase price payments are dependent on Access achieving certain EBITDA levels.  The

maximum amount of the consideration that may be paid to the seller of Access, including the closing date purchase price consideration and investment banking, valuation and legal and accounting fees, is $9,773,500.  The amount of contingency payments and common stock deliveries based upon EBDITA through December 31, 2006, will be based upon a 3.22 multiple of EBITDA of Access determined on a quarterly basis, with effective adjustments as of December 31, 2004, 2005 and 2006.  During the first nine months of 2005, Access’ performance to date resulted in an obligation to convey quarterly cash payments of $560,000 (paid in April 2005), $525,000 (paid in July 2005) and $625,000 (paid in October 2005) related to the first, second and third quarters, respectively, plus the issuance of 320,473 common shares (issued in April 2005), 575,134 common shares (issued in August 2005) and 452,986 common shares (issued in October 2005), valued at $560,000,  $525,000 and $625,000, respectively. The number of shares issued was based upon the average trading price for the last ten days of each quarter. These obligations as of September 30, 2005 are reported as a current liability in the accompanying balance sheet.  The cumulative purchase price, including contingent payments made or earned through September 30, 2005, is $7,087,000.  The Company expects that Access may further achieve those EBITDA levels and that, as a result, additional contingent payouts may be made. However, the amount of payouts through December 31, 2006 cannot be estimated at this time. The contingency payout will be accounted for as a decrease in the Company’s cash and cash equivalents for the amount paid, an increase to stockholders’ equity for the fair value of shares issued and a corresponding increase in goodwill for the value of the cash paid and stock issued.

 

Note 6—Segmented Information

 

The Company discloses segment information in accordance with SFAS No. 131, “Disclosure About Segments of an Enterprise and Related Information,” which requires companies to report selected segment information on a quarterly basis and to report certain entity-wide disclosures about products and services, major customers, and the material countries in which the entity holds assets and reports revenues. The Company has four reportable segments: Consumer Healthcare Savings, self-funded Employer and Group Healthcare Services, Membership Programs and Financial Services. The Company’s reportable segments are strategic divisions that offer different services and are managed separately as each division requires different resources and marketing strategies.  Our Consumer Healthcare Savings segment, our largest segment, offers savings on healthcare services to persons who are un-insured, under-insured, or who have elected to purchase only high deductible or limited benefit medical insurance policies, by providing access to the same preferred provider organizations (PPOs) that are utilized by many insurance companies and employers who self-fund at least a portion of their employees’ healthcare risk. These programs are sold primarily through a network marketing strategy.  Our self-funded Employer and Group Healthcare Services segment provides a wide range of healthcare claims administration services and other cost containment procedures that are frequently required by governments and other large employers who have chosen to self-fund their healthcare benefits requirements.  Our Membership Division offers non-healthcare related membership programs for rental-purchase companies, financial organizations, employer groups, retailers and association-based organizations. Substantially all of our non-healthcare related membership service programs are offered and sold at retail by clients engaged in the rental-purchase industry.  Our Financial Services segment provides high deductible and scheduled benefit insurance policies, life insurance and annuities and health savings accounts, healthcare reimbursement arrangements and medical and dependent care flexible spending accounts.

 

The accounting policies of the segments are consistent with those described in the summary of significant accounting policies in Note 2 of the Company’s audited financials, included in its December 31, 2004 Form 10-K, intersegment sales are not material and all intersegment transfers are eliminated. During 2004, the Company increased the number of segments from one to four, excluding its corporate activities.

 

No one customer represents more than 5% of the Company’s overall revenue. Therefore, the Company does not believe it has a material reliance on any one customer. The Company operates in substantially all of the fifty states in the U.S. but not in any foreign countries.

 

The Company evaluates segment performance based on revenues and income before provision for income taxes. The Company does not allocate income taxes or unusual items to the segments.

 

Certain prior period amounts have been reclassified to conform to the current period’s presentation.

 

29



 

The following table (in 000’s) summarizes segment information:

 

 

 

 

 

Employer and

 

 

 

 

 

 

 

 

 

 

 

Consumer

 

Group

 

 

 

 

 

 

 

 

 

 

 

Healthcare

 

Healthcare

 

Membership

 

Financial

 

 

 

 

 

Three Months Ended September 30, 2005

 

Savings

 

Services

 

Programs

 

Services

 

Corporate

 

Total

 

Revenue (1)

 

$

4,931

 

$

2,217

 

$

317

 

$

71

 

$

 

$

7,536

 

Operating Income (Loss) (1)

 

178

 

488

 

52

 

(89

)

(458

)

171

 

Interest Expense (Income)

 

¾

 

¾

 

¾

 

¾

 

(60

)

(60

)

Depreciation and Amortization

 

175

 

74

 

2

 

6

 

¾

 

257

 

Taxes (2)

 

¾

 

¾

 

¾

 

¾

 

101

 

101

 

Assets Acquired, net of disposals

 

57

 

8

 

¾

 

¾

 

¾

 

65

 

Intangible Assets (2)

 

¾

 

¾

 

¾

 

¾

 

16,197

 

16,197

 

Assets Held

 

9,163

 

2,558

 

75

 

61

 

20,333

 

32,190

 

 

 

 

 

 

Employer and

 

 

 

 

 

 

 

 

 

 

 

Consumer

 

Group

 

 

 

 

 

 

 

 

 

 

 

Healthcare

 

Healthcare

 

Membership

 

Financial

 

 

 

 

 

Three Months Ended September 30, 2004

 

Savings

 

Services

 

Programs

 

Services

 

Corporate

 

Total

 

Revenue (1)

 

$

7,902

 

$

1,838

 

$

239

 

$

312

 

$

 

$

10,291

 

Operating Income (Loss) (1)

 

496

 

325

 

(4

)

(267

)

(259

)

291

 

Interest Expense (Income)

 

¾

 

¾

 

¾

 

¾

 

7

 

7

 

Depreciation and Amortization

 

550

 

6

 

3

 

5

 

¾

 

564

 

Taxes (2)

 

¾

 

¾

 

¾

 

¾

 

188

 

188

 

Assets Acquired, net of disposals

 

161

 

76

 

¾

 

8

 

¾

 

245

 

Intangible Assets (2)

 

¾

 

¾

 

¾

 

¾

 

24,273

 

24,273

 

Assets Held

 

11,692

 

5,785

 

1,711

 

97

 

25,275

 

44,560

 

 

 

 

 

 

Employer and

 

 

 

 

 

 

 

 

 

 

 

Consumer

 

Group

 

 

 

 

 

 

 

 

 

 

 

Healthcare

 

Healthcare

 

Membership

 

Financial

 

 

 

 

 

Nine Months Ended September 30, 2005

 

Savings

 

Services

 

Programs

 

Services

 

Corporate

 

Total

 

Revenue (1)

 

$

16,746

 

$

6,436

 

$

788

 

$

303

 

$

 

$

24,273

 

Operating Income (Loss) (1)

 

(3

)

1,375

 

95

 

(537

)

(11,722

)

(10,792

)

Interest Expense (Income)

 

¾

 

¾

 

¾

 

¾

 

(99

)

(99

)

Depreciation and Amortization

 

1,267

 

208

 

5

 

16

 

¾

 

1,496

 

Taxes (2)

 

¾

 

¾

 

¾

 

¾

 

54

 

54

 

Assets Acquired, net of disposals

 

608

 

17

 

¾

 

2

 

¾

 

627

 

Intangible Assets (2)

 

¾

 

¾

 

¾

 

¾

 

16,197

 

16,197

 

Assets Held

 

9,163

 

2,558

 

75

 

61

 

20,333

 

32,190

 

 

 

 

 

 

Employer and

 

 

 

 

 

 

 

 

 

 

 

Consumer

 

Group

 

 

 

 

 

 

 

 

 

 

 

Healthcare

 

Healthcare

 

Membership

 

Financial

 

 

 

 

 

Nine Months Ended September 30, 2004

 

Savings

 

Services

 

Programs

 

Services

 

Corporate

 

Total

 

Revenue (1)

 

$

26,138

 

$

2,290

 

$

675

 

$

538

 

$

 

$

29,641

 

Operating Income (Loss) (1)

 

3,145

 

488

 

(118

)

(727

)

(777

)

2,011

 

Interest Expense (Income)

 

¾

 

¾

 

¾

 

¾

 

57

 

57

 

Depreciation and Amortization

 

1,632

 

7

 

9

 

12

 

¾

 

1,660

 

Taxes (2)

 

¾

 

¾

 

¾

 

¾

 

964

 

964

 

Assets Acquired, net of disposals

 

504

 

77

 

¾

 

32

 

¾

 

613

 

Intangible Assets (2)

 

¾

 

¾

 

¾

 

¾

 

24,273

 

24,273

 

Assets Held

 

11,692

 

5,785

 

1,711

 

97

 

25,275

 

44,560

 

 

 


        (1) – Certain prior period amounts have been reclassified to conform to the current period’s presentation.

 

        (2) – Intangible assets and income tax expense (benefit) are not allocated to the assets and operations of the related segment.

 

30